相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide
Xue Qing Lun et al.
CLINICAL CANCER RESEARCH (2009)
Molecular mechanisms of mTOR-mediated translational control
Xiaoju Max Ma et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Modeling Adult Gliomas Using RCAS/t-va Technology
Dolores Hambardzumyan et al.
TRANSLATIONAL ONCOLOGY (2009)
Cancer stem cells and survival pathways
Dolores Hambardzumyan et al.
CELL CYCLE (2008)
Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo
Marianne M. Stanford et al.
MOLECULAR THERAPY (2008)
Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death
Marta M. Alonso et al.
MOLECULAR THERAPY (2008)
Translational control of the innate immune response through IRF-7
Rodney Colina et al.
NATURE (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
RAPping production of type I interferon in pDCs through mTOR
Mauro Costa-Mattioli et al.
NATURE IMMUNOLOGY (2008)
Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3) K-mTOR-p70S6K pathway
Weiping Cao et al.
NATURE IMMUNOLOGY (2008)
Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis
Thi Lien-Anh Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin
Xue Qing Lun et al.
CANCER RESEARCH (2007)
Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo
M. M. Alonso et al.
CANCER GENE THERAPY (2007)
Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells
Guido Wollmann et al.
JOURNAL OF VIROLOGY (2007)
Effects of intravenously administered recombinant vesicular stomatitis virus (VSVΔM51) on Multifocal and invasive gliomas
XueQing Lun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Intracellular pattern recognition receptors in the host response
Etienne Meylan et al.
NATURE (2006)
Antiviral effect of the mammalian translation initiation factor 2α kinase GCN2 against RNA viruses
Juan J. Berlanga et al.
EMBO JOURNAL (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: Correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect
O Szentirmai et al.
NEUROSURGERY (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors
Kenya Honda et al.
NATURE REVIEWS IMMUNOLOGY (2006)
RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer
K Homicsko et al.
CANCER RESEARCH (2005)
S6K1-/-/S6K2-/- mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway
M Pende et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Bioluminescence imaging of the response of rat gliosarcoma to ALA-PpIX-mediated photodynamic therapy
EH Moriyama et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2004)
Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: Racine and nonhuman primates
WQ Yang et al.
CLINICAL CANCER RESEARCH (2004)
La autoantigen is necessary for optimal function of the poliovirus and hepatitis C virus internal ribosome entry site in vivo and in vitro
M Costa-Mattioli et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Resistance to vesicular stomatitis virus infection requires a functional cross talk between the eukarvotic translation initiation factor 2α kinases PERK and PKR
D Baltzis et al.
JOURNAL OF VIROLOGY (2004)
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
DF Stojdl et al.
CANCER CELL (2003)
Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity
M Obuchi et al.
JOURNAL OF VIROLOGY (2003)
Gene expression profiling identifies molecular subtypes of gliomas
R Shai et al.
ONCOGENE (2003)
Viruses and interferon: A fight for supremacy
MG Katze et al.
NATURE REVIEWS IMMUNOLOGY (2002)
PKR protection against intranasal vesicular stomatitis virus infection is mouse strain dependent
RK Durbin et al.
VIRAL IMMUNOLOGY (2002)
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
DF Stojdl et al.
NATURE MEDICINE (2000)
分享论文
